CBT profiles of cabozantinib approved for advanced renal cell carcinomas.

Item

http://www.wikidata.org/entity/Q53782217

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

CBT profiles of cabozantinib approved for advanced renal cell carcinomas.

@en

CBT profiles of cabozantinib approved for advanced renal cell carcinomas.

@nl

type

Item

label

CBT profiles of cabozantinib approved for advanced renal cell carcinomas.

@en

CBT profiles of cabozantinib approved for advanced renal cell carcinomas.

@nl

prefLabel

CBT profiles of cabozantinib approved for advanced renal cell carcinomas.

@en

CBT profiles of cabozantinib approved for advanced renal cell carcinomas.

@nl

P1476

CBT profiles of cabozantinib approved for advanced renal cell carcinomas.

@en

P2093

Xiangdong Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular Determinants Underlying Binding Specificities of the ABL Kinase Inhibitors: Combining Alanine Scanning of Binding Hot Spots with Network Analysis of Residue Interactions and Coevolution

Dynamic gene expressions of peripheral blood mononuclear cells in patients with acute exacerbation of chronic obstructive pulmonary disease: a preliminary study

Kinase and BET Inhibitors Together Clamp Inhibition of PI3K Signaling and Overcome Resistance to Therapy.

Receptor tyrosine kinase transmembrane domains: Function, dimer structure and dimerization energetics.

Association of chromosome 19 to lung cancer genotypes and phenotypes.

New structural and functional insight into the regulation of Ras.

SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.

Characterization of V-ATPase inhibitor-induced secretion of cysteine-rich with EGF-like domains 2.

Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth.

Gene mutation-based and specific therapies in precision medicine.

P2888

s10565-016-9349-6

P304

259-261

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1007/S10565-016-9349-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27383755

http://www.w3.org/2001/XMLSchema#string